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The transcription factor p53 plays a critical role in maintain-
ing homeostasis as it relates to cellular growth, proliferation,
andmetabolism. In an effort to identify novel p53 target genes, a
microarray approach was utilized to identify DHRS3 (also
known as retSDR1) as a robust candidate gene. DHRS3 is a
highly conserved member of the short chain alcohol dehydro-
genase/reductase superfamily with a reported role in lipid and
retinoid metabolism. Here, we demonstrate that DHRS3 is an
endoplasmic reticulum (ER) protein that is shuttled to theERvia
an N-terminal endoplasmic reticulum targeting signal. One
important function of the ER is synthesis of neutral lipids that
are packaged into lipid droplets whose biogenesis occurs from
ER-derived membranes. DHRS3 is enriched at focal points of
lipid droplet budding where it also localizes to the phospholipid
monolayer of ER-derived lipid droplets. p53 promotes lipid
droplet accumulation in a manner consistent with DHRS3
enrichment in the ER. As a p53 target gene, the observations of
Dhrs3 location and potential function provide novel insight into
an unexpected role for p53 in lipid droplet dynamics with impli-
cations in cancer cell metabolism and obesity.
The MDM2-p53 stress response pathway is an important
regulator of cellular homeostasis. A variety of mitogenic and
genotoxic stressors converge on this pathway to elicit a protec-
tive p53-dependent stress response resulting in cell cycle arrest,
apoptosis, DNA repair, or replicative senescence (1). Research
over the past decade has begun to emphasize the role of p53 in
regulating cell metabolism under “nonstressed” conditions.
Specifically, p53 has been implicated in regulating a number of
target genes involved in energy metabolism, including phos-
phoglycerate mutase (2), a glycolytic enzyme that catalyzes the
reversible conversion of 3-phosphoglycerate to 2-phosphoglyc-
erate, Synthesis of cytochrome c oxidase 2 (3), which regulates
the cytochrome c oxidase complex of the electron transport
chain, TIGAR (TP53-induced glycolysis and apoptosis regula-
tor), a gene that inhibits glycolysis by lowering fructose-2.6-
bisphosphate levels(4), and guanidinoacetate methyltrans-
ferase, an enzyme critical for creatine biosynthesis (5). Here, we
expand the metabolic spectrum for p53 by reporting a novel
target gene, DHRS3, as a lipid droplet protein with potential
ramifications for lipid and retinoid metabolism.
DHRS3 is a highly conservedmember of the short chain alco-
hol dehydrogenase/reductase superfamily and has been impli-
cated in retinol (vitamin A)metabolism. Retinol comprises one
member of the retinoid family of chemical compounds that
influence several aspects of cellular biology, including prolifer-
ation and differentiation, primarily through regulation of gene
expression (6). Retinoic acid (RA),4 one of the major biologi-
cally activemolecules of the retinoid family, is primarily derived
from oxidation of all-trans-retinaldehyde (retinal), an unstable
intermediate that fluxes between retinol and RA. Because reti-
nol cannot be synthesized in mammalian systems, it must be
absorbed and esterified as retinyl esters to facilitate storage in
cytoplasmic lipid droplets (6). The primary storage depots in
humans are hepatocytes and adipocytes, where retinyl esters
are estimated to account for 70 and 20% of retinyl ester accu-
mulation, respectively (7, 8). DHRS3 was first identified as hav-
ing similar enzymatic activity to all-trans-retinol dehydroge-
nases and subsequently shown to facilitate the reduction of
retinal to retinol in the visual cycle of cone photoreceptors (9).
Furthermore, ectopic expression of DHRS3 in neuroblastoma
cells was reported to increase retinyl ester concentrations, sup-
porting the role of DHRS3 as a retinal reductase in generating
storage forms of retinol (10). Retinoic acid signaling also regu-
lates body patterning and morphogenesis, where in Xenopus,
DHRS3 was demonstrated to be expressed during various
stages of embryonic development and neurulation (11).
Lipid droplets have been appreciated previously as inert stor-
age vesicles for triacylglycerol, as well as cholesterol, sterol, and
retinyl esters (12). However, recent evidence has begun to high-
light the role of the lipid droplet as a functional and dynamic
organelle. Despite controversy regarding the precisemechanis-
tic details surrounding lipid droplet biogenesis, a common
thread among all models maintains that triacylglycerol synthe-
sis in the lumen of the endoplasmic reticulum forces budding of
the outer, cytosolic ER leaflet, which subsequently forms into
an independent droplet with a singular ER-derived phospho-
lipid monolayer (12). Although lipid droplets have been largely
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studied in the context of steroidigenic and lipid storage tissues,
they are found in essentially all cell types.
Here, we identify Dhrs3 as a novel p53 target gene that is
localized to the endoplasmic reticulum and lipid droplets.
DHRS3 is selectively transported to the ER where it appears
to concentrate at regions of lipid droplet accumulation.
Given that lipid droplets are synthesized from the outer ER
membrane, DHRS3 also localizes to lipid droplets both in an
endogenous and induced manner. DHRS3 expression is
enhanced in retinol storing tissues where it may be involved in
promoting retinyl ester storage in nascent lipid droplets.
Finally, a previously unidentified and novel role for p53 in pro-
moting lipid droplet accumulation is demonstrated to correlate
to Dhrs3 transactivation.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents—U2OS, ZR-75–1, MDA-MB-
175VII, MCF-7, HepG2, and mouse embryo fibroblasts (MEF)
cell lines were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum, L-gluta-
mine, 100 g/ml penicillin, and 100 g/ml streptomycin at 5%
CO2 in a humidified chamber. 3T3-L1 preadipocytes were
maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% Colorado calf serum, 100 g/ml penicillin,
and 100 g/ml streptomycin at 5% CO2 in a humidified cham-
ber. Cell transfections were carried out with FugeneHD (Roche
Applied Science) reagents. 4-Hydroxytamoxifen, 3-isobutyl-1-
methylxanthine, dexamethasone, and oleic acid were pur-
chased from Sigma. Bovine insulin was purchased from Invit-
rogen. Mammalian protein extraction reagent purchased from
Thermo Scientific. Primary MEF were isolated on embryonic
day 13.5 and grown in a 37 °C incubatorwith 5%CO2 inDMEM
supplied with 10% FBS and penicillin-streptomycin.
Plasmids andAdenovirus—Togenerate a humanDhrs3-GFP
fusion expression construct, the full-length DHRS3 cDNA
(Open Biosystems) was amplified by PCR and cloned into
pEGFP-NI (Clontech). The ADEASY XL system (Stratagene)
was used for creating adenovirus. DNA sequences were sub-
cloned into pShuttle-CMV, recombinedwith pADEASY-1 vec-
tor, and transfected into 293 QBT cells to generate an
adenovirus.
Microarray Analysis—Total RNA was isolated from MEFs
treated with 4-hydroxytamoxifen (4-OHT) for 12 and 24 h
using an RNeasy kit (Qiagen). 1 g of total RNA was amplified
and labeled using the low RNA input linear amplification kit
(Agilent Technologies), and hybridization was performed on
Agilent 4  44 K mouse whole genome DNA microarrays at
UNC Genomics and Bioinformatics core facility. Arrays were
washed and scanned using an Agilent scanner (Agilent Tech-
nologies). Data are stored in the University of North Carolina
Microarray Database. Genes that were significantly up- or
down-regulated were identified using significance analysis of
microarrays.
Adipocyte Differentiation Assay—3T3-L1 preadipocytes
(passages 9–12) were grown to 2 days post-confluence. Adi-
pocyte differentiation media containing 10% FBS, 4 g/ml
bovine insulin, 1Mdexamethasone, and 0.5mM isobutylmeth-
ylxanthine was added to the cells for 2 days, switched to media
containing only 10% FBS and insulin for two more days, and
then maintained in media with 10% FBS for 4–5 days.
Transmission Electron Microscopy—HepG2/U2OS cells
were fixed with 4% buffered paraformaldehyde in 0.15 M
sodium phosphate buffer (PB), pH 7.4, for 45 min. Following
permeabilization with 0.01% digitonin in PB for 30 min at RT,
the cells were washed in PB and blocked using Aurion blocking
solution for 30 min. Cells were incubated overnight at 4 °C in
primary antibody (rabbit anti-DHRS3, diluted to 3 g/ml in
PB/0.2% acetylated BSA). After PB/BSA washes, the cells were
incubated overnight at 4 °C in colloidal gold antibody diluted to
1:50 in PB/BSA. Following silver enhancement to enlarge gold
particles for 90 min, the cells were post-fixed in 0.5% PB-buff-
ered osmium tetroxide for 15 min, dehydrated in ethanol, and
FIGURE 1. Dhrs3 is a p53-inducible gene. A, mouse embryonic fibroblasts
harboring a single p53ER fusion allele and a single p53 null allele (p53 ER/-
MEF) cell lines with the indicated Mdm2 genotypes were treated for 12 and
24 h with 4-OHT. Cells were harvested and analyzed by Western blot. B, cor-
responding microarray Log2 expression values of p53 ER/-MEF cell lines fol-
lowing 24 h treatment with 4-OHT. C, p53 ER/-MEF cell lines with the indicated
Mdm2 genotypes were treated for 24 h with 4-OHT. Cells were harvested and
analyzed by Western blot.
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embedded in PolyBed-812 epoxy resin (Polysciences, Inc.,
Warrington, PA). 80-nm Ultrathin sections were cut with a
diamond knife, mounted on grids and stained with 4% aqueous
uranyl acetate and Reynolds’ lead citrate. Samples were
observed using a LEO EM910 transmission electron micro-
scope operating at 80 kV (Carl Zeiss SMT, Inc., Peabody, MA)
and digital images were acquired using a Gatan Orius SC1000
CCD digital camera with digital micrograph software (version
3.11.0; Gatan, Inc., Pleasanton, CA). Immunostaining reagents
(all from Electron Microscopy Sciences, Fort Washington, PA)
used in this study were as follows: Aurion blocking solution for
goat gold conjugates (catalog no. 25596), Aurion acetylated
BSA-c (catalog no. 25558), Aurion goat anti-rabbit IgG (HL)
Ultrasmall EM grade 0.8 nm colloidal gold (catalog no. 25101),
and Aurion R-Gent SE-EM silver enhancement kit (catalog no.
25521).
Immunofluorescence and Confocal Microscopy—Monolayer
cells were fixed with formaldehyde, permeabilized by 0.2% Tri-
ton X-100 (for endoplasmic reticulum staining) or 0.01% digi-
tonin (for lipid droplets) and stained with primary anti-DHRS3
FIGURE 2. DHRS3 is a highly conserved protein. The eight annotated protein sequences of species-specific DHRS3 were aligned for sequence similarity
analysis.
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(PTG 15393-1-AP) antibody. Goat anti-rabbit Cy2 secondary
antibody was purchased commercially (Jackson Immuno-
Research Laboratories). LipidTOX Red (Invitrogen) was used
for neutral lipid staining, and DAPI was used for nuclear
demarcation. Immunostained cells were analyzed using an
Olympus IX-81 microscope fitted with a SPOT camera and
software.
For confocal microscopy, cells were grown on in 35-mm
glass-bottomed dishes (MatTek) and processed in an identical
manner for immunofluorescence staining. Samples were ana-
lyzed on a Zeiss 710 LSM confocal laser-scanning microscope
with a 40 or 63 oil immersion objective. Raw image data were
deconvolved using AutoDeblur (version X1.4.1) and imaged in
Imarus X64 (version 7.1.1).
Antibodies—The following antibodies were purchased com-
mercially: mouse anti-Mdm2 2A10 (University of North Caro-
lina Tissue Culture and Molecular Biology Support Facility),
mouse anti-actin (Neomarkers), mouse anti-p53 DO.1 (Neo-
markers), rabbit anti-DHRS3 (ProteinTech Group 15393-1-AP
for immunostaining, SigmaHPA010844 forWestern blot), rab-
bit anti-CALR (ProteinTech Group 10292-1-AP), and goat
anti-p21 (C-19) (Santa Cruz Biotechnology).
LipidTOX Red and Oil Red O Staining—Cells were fixed in
formalin, washed with PBS, and incubated with a 60% isopro-
panol/dH2O solution for 5 min. An Oil Red O stock solution
(0.5 g/100 ml isopropyl alcohol), diluted to 60% in water and
filtered through 0.45msyringe filter, was added to the cells for
10 min, then washed with water until the rinse was clear. For
LipidTOX staining, cells were fixed, washed in PBS, and incu-
batedwith a 1:1000 dilution of LipidTOX inPBS for aminimum
of 30 min.
Biochemical Fractionations—An optimized differential de-
tergent fractionation procedure was utilized as described pre-
viously (13).
RESULTS
Dhrs3 Is a p53-inducible Gene—A previous study by our lab-
oratory (14) aimed at dissecting the function of MDM2
required the generation of mice bearing Mdm2 WT, null, or
RING finger C462A point mutation alleles. In addition, to pre-
serve viability of the mice for further study, they were intro-
duced with the switchable p53ERTAM (p53ER) allele (15) to
facilitate modulation of p53 function. p53ER expresses a WT
p53 protein fused at the C terminus to the hormone binding
domain of the estrogen receptor and is transcriptionally regu-
lated in the same manner as the WT allele. In the absence of
4-OHT ligand binding, p53ER does not bind toDNAand there-
fore exhibits little transactivation function. However, in the
presence of ligand binding, the p53ER fusion protein functions
relatively normally, transcribing downstream target genes.
During our studies with MEF harboring the p53ER fusion
protein with the three indicated Mdm2 alleles, we observed
differential p53 transactivation potential. As expected, follow-
ing 4-OHT treatments for 12 or 24 h, Mdm2 WT MEF cells
induced Mdm2, subsequently reducing total p53 levels with
modest induction of p21 levels over the time course. TheMdm2
knock-out MEF exhibited sustained p53 stability with greater
levels of p21 induction, a result that was expected due to the
complete absence of MDM2 protein. Surprisingly, p53 activa-
tion in the Mdm2 C462A MEF, where an E3 ligase-deficient
MDM2 is expressed, resulted in not only p53 activation as
shown previously (14), but even higher levels of p53 transacti-
vation as compared with the complete Mdm2 knock-out (Fig.
1A). Based on these observations, it was clear that p53ER trans-
activation potential could be represented as low,moderate, and
high acrossMdm2WT, null, and C462A MEF, respectively.
Because theMEF cell lines provided a unique system to study
physiological levels of differential p53 transactivation potential
without the confounding variables of genotoxic or cytotoxic
stress normally required to stabilize p53, we performed a
microarray experiment screening for novel p53 candidate tar-
get genes. As a means of validation of the screening, we identi-
fied a large number of the genes identified previously in a ChIP-
chip array (16). The most robust candidates also met the
arbitrary low-moderate-high Log2 expression threshold we
observed in our MEFWestern analysis for p21.
One robust candidate gene was Dhrs3, an oxidoreductase
with significant homology to SDR (short-chain alcohol dehy-
drogenase/reductase) enzymes. AlthoughDhrs3 induction was
low in theMdm2WTMEF after p53 activation, theMdm2 null
and C462A MEF had moderate-to-high expression of Dhrs3,
respectively (Fig. 1B). The induced protein levels mirrored the
Log2 expression values indicated by the microarray (Fig. 1C),
thereby providing a strong correlation between transcript and
protein levels. After our identification of Dhrs3 as a potential
p53 target gene, another group published similar findings pro-
viding evidence for Dhrs3 as a bona fide direct p53 target gene
(17). Given their findings, we sought to further characterize the
localization and function of DHRS3.
DHRS3 Is an Endoplasmic Reticulum Protein—The DHRS3
protein sequence alignment among all known species specific
alleles reveals a high degree of conservation with 98.7% homol-
ogy and 70.2% identity down to zebrafish (Fig. 2), suggesting
thatDHRS3 is well conservedwith a potential recent evolution-
ary divergence in eukaryotic organisms. Prediction of DHRS3
subcellular localization by computer algorithm (18) placed
DHRS3 in the endoplasmic reticulum. To gain further insight
into potential DHRS3 localization, a DHRS3-GFP fusion con-
struct was generated expressing GFP at the C terminus of WT
DHRS3. Expression of GFP alone was diffuse throughout the
cell with a heavy concentration to the nucleus and did not co-
localizewith the ERprotein calreticulin. DHRS3-GFP exhibited
significant perinuclear expression with punctuate structures
FIGURE 3. DHRS3 is an endoplasmic reticulum protein. A, U2OS cells were transfected with constructs expressing GFP or a DHRS3-GFP fusion protein for 24 h.
Calreticulin (Calr) is an ER marker, and DAPI demarcates the nucleus. B, ZR-75-1, MDA-MB-175III, and HepG2 cells were partitioned into total (Tot), cytosolic-
enriched (Cyto), or ER-enriched fractions and analyzed by Western blot. Actin is a cytosolic marker; calreticulin is an ER marker. C, a hydropathy plot of human
DHRS3. The x axis represents amino acid position and the y axis represents amino acid hydropholicity (negative score) and hydrophobicity (positive score). The
predicted endoplasmic reticulum targeting signal (ERTS) is shown. D, U2OS cells were transfected with GFP alone or the indicated DHRS3 fusion constructs for
24 h. The cells were immunostained for calreticulin, an ER control, and stained for DAPI to demarcate the nucleus.
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present within the same region. The diffuse perinuclear stain-
ing co-localized with calreticulin, suggesting that DHRS3 is an
ER protein (Fig. 3A). Furthermore, HepG2 cells and two breast
cancer cell lines ZR-75–1 andMDA-MB-175III were subjected
to differential detergent fractionation (13) to separate cytosolic
from ER proteins. All three cell types carry aWT p53 allele and
express relatively high levels of DHRS3. DHRS3 was enriched
with the calreticulin fraction and did not appear with actin in
the cytosolic fraction (Fig. 3B). Thus, we identify DHRS3 is
primarily an ER protein.
Proteins destined for the ER generally require transport in
the form of a selective sorting signal. In the case of ER proteins,
many undergo translocation to the ER during translation in a
process requiring an N-terminal targeting signal with approxi-
mate length of 20–30 amino acids containing an internal
hydrophobic patch of residues (19). Although a high degree of
conservation was found in terms of amino acid homology
among species-specific DHRS3, the greatest degree of hetero-
geneity occurred in the N terminus (Fig. 2). A hydropathy plot
of human DHRS3 exposed a stretch of strongly hydrophobic
residues at the N terminus (Fig. 3C), consistent with a putative
functional ER targeting signal. In addition, the subcellular pre-
diction tool TargetP 1.1 (18) predicted an N-terminal sorting
signal of 23 amino acids. To determine if the N-terminal 23
amino acids of DHRS3 could function as an ER sorting signal,
GFP fusion constructs were expressed to trackDHRS3 localiza-
tion. As expected, full lengthDHRS3-GFP localized to the ER in
a manner consistent with the calreticulin signal (Fig. 3D).
Expression of theN-terminal 23-amino acid truncationmutant
of DHRS3-GFP (DHRS3-GFP ERTS) resulted in a more dif-
fuse cytosolic signal, as well as nuclear accumulation, that was
similar to GFP expression alone. Furthermore, expression of an
N-terminal GFP fusion protein containing exclusively the first
23 amino acids of DHRS3 showed partial localization to the ER
and enhanced nuclear exclusion. Taken together, this suggests
that the N-terminal 23 amino acids of DHRS3 are primarily
necessary and sufficient to support translocation to the ER
membrane.
DHRS3 Associates with Lipid Droplets in Hepatocytes—The
liver serves as the primary storage tissue for retinoids, account-
ing for 70% of whole body retinoid storage (7). Specifically, a
subfraction of hepatocytes, termed hepatic stellate cells, store
retinol, in the form of retinyl esters, in cytoplasmic lipid drop-
lets. Lipid droplets are considered to be primarily storage
organelles for intracellular triacylglycerol, as well as choles-
terol, sterol, and retinyl esters (20). The biosynthesis of lipid
droplets occurs at the outer, cytosolic leaflet of the endoplasmic
reticulum, where increasing concentrations of newly synthe-
sized triacylglycerol in the ER lumen is thought to force “bud-
ding” at the ER, ultimately resulting in a neutral lipid droplet
comprised of an ER-derived phospholipid monolayer (12). In
conjunction with the observations of DHRS3-GFP at the ER,
additional punctuate, spherical structureswere present that did
not co-localize with the ERmarker. Given that DHRS3 is highly
expressed in the hepatocellular carcinoma cell line HepG2 (Fig.
3C) and is reported to be a retinal reductase (9, 10), thereby
promoting increased retinol substrate for esterification and
storage, we reasoned that the additional observed localization
may be concentrated to lipid droplets. After validating the anti-
body, immunostaining for endogenous DHRS3 in HepG2
revealed consistent halo structures that were concentrated to
the perinuclear space (Fig. 4A). Neutral lipids are most abun-
dant in cytoplasmic lipid droplets, so using a neutral lipid stain,
LipidTOX Red, it was apparent that the concentrated DHRS3
halo structures extensively co-localized with lipid droplets (Fig.
4A). To gain further insight into the association of DHRS3 with
lipid droplets, confocal scanning laser microscopy was per-
formed on endogenous DHRS3 in HepG2 cells. A single cross-
section (z-slice) of a HepG2 colony reveals that DHRS3 expres-
sion is concentrated to regions where lipid droplets are found
(Fig. 4B). In addition, DHRS3 is also localized to the droplet
monolayer in a fraction of lipid droplets observed. The compos-
ite Z-stack reveals significant overlap of the DHRS3 and Lipid-
TOXRed signal, indicating that DHRS3 is indeed concentrated
to regions of lipid droplet formation and may be directly asso-
ciated with a subfraction of nascent droplets. Finally, immuno-
gold labeling of endogenous DHRS3 indicates significant
enrichment to both the ER foci of lipid droplet formation (Fig.
4C) but also to the outer phospholipidmonolayer of lipid drop-
lets (Fig. 4D). These results consistently demonstrate that
DHRS3 is an ER protein concentrated to potential focal points
of lipid droplet budding where it can also localize to the phos-
pholipid monolayer of newly synthesized droplets.
DHRS3 Is Expressed in Mature Adipocytes—Adipocytes are
secondary only to the liver in terms of retinoid storage,
accounting for upwards of 15–20% of total body retinol (8).
Given the observations that DHRS3was expressed and concen-
trated to regions of lipid droplets in retinoid-storing hepato-
cytes, we investigated the expression and localization ofDHRS3
in adipocytes. Using the standard murine 3T3-L1 preadipocyte
cell line (21), we induced adipocyte differentiation over an
8-day period to assess DHRS3 expression. Differentiation was
validated by staining the cells with the neutral lipid stain Oil
RedO.Minimal protein expressionwas observed prior to day 3,
including the subconfluent population. By days 4–8, coincid-
ingwith the onset of visible lipid accumulation and lipid droplet
formation, DHRS3 levels gradually increased (Fig. 5A). Despite
the overall decrease in actin levels, DHRS3 levels continue to go
up, signifying enhanced expression in mature adipocytes.
Immunofluorescent labeling of endogenous DHRS3 in mature
adipocytes illustrates enrichment of DHRS3 in the cytosolic
space, consistent with up-regulated ER localization. In addi-
tion, halo structures, correlating to the lipid droplets, were also
observed (Fig. 5B), suggesting that DHRS3 may be associated
FIGURE 4. DHRS3 associates with lipid droplets in hepatocytes. A, immunofluorescence staining of endogenous DHRS3 in HepG2 cells. LipidTOX Red marks
the lipid droplets, and DAPI marks the nucleus. B, confocal scans of endogenous DHRS3 in HepG2 cells. Both a single z-slice and the composite z-stack are
shown. LipidTOX Red marks the lipid droplets, and DAPI marks the nucleus. Scale bar, 15 m. C and D, transmission electron microscopy of immunogold-
labeled endogenous DHRS3 in HepG2 cells. HepG2 monolayers were fixed, probed with secondary antibody alone (left) or -DHRS3 primary antibody (right),
and visualized by transmission electron microscopy. Representative lipid droplets (LD) and nucleus (N) are indicated. Arrows denote point of interest.
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with adipocyte lipid droplets as well. 3T3-L1 cells at terminal
stages of differentiation were subjected to confocal microscopy
to further gauge DHRS3 association with lipid droplets (Fig.
5C). The cells with the largest lipid droplets, indicative of a
mature adipocyte phenotype, had the greatest saturation of
DHRS3 signal in a manner consistent with the differentiation
assay. In contrast, cells at more immature or intermediate
stages of differentiation with little to no large lipid droplets,
illustrated significantly decreased signal intensity for DHRS3.
Together, the data suggest that enhanced DHRS3 expression at
the ER is correlated to increased size and frequency of lipid
droplet formation in mature adipocytes.
FIGURE 5. DHRS3 is expressed in mature adipocytes. A, 3T3-L1 preadipocytes were induced to differentiate over an 8-day period. Representative samples
were fixed and stained each day with Oil Red O and analyzed under phase-contrast microscopy. Cells were also harvested and analyzed by Western blot.
Subconfluent (SC) and days 0 – 8 were probed for DHRS3 expression. B, immunofluorescence staining of endogenous DHRS3 in mature 3T3-L1 adipocytes.
Preadipocytes were induced to differentiate over 8 days and processed for analysis. LipidTOX Red marks the lipid droplets, and DAPI marks the nucleus.
C, confocal scans of endogenous DHRS3 in mature 3T3-L1 adipocytes. Both a single z-slice and the composite z-stack are shown. LipidTOX Red marks the lipid
droplets, and DAPI marks the nucleus.
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Lipid Droplet Formation Induces Delocalization of DHRS3
from ER to Lipid Droplets—As the primary storage depot for
newly synthesized triacylglycerol, lipid droplet biogenesis is
sensitive to the degree of fatty acid availability.De novo triacyl-
glycerol synthesis is catalyzed by a suite of enzymes localized to
the ER and outermitochondrialmembranes (22). Excessive free
fatty acid levels are known to induce lipid droplets (23), in part,
through enhanced triacylglycerol synthesis and storage. Be-
cause endogenous DHRS3 localizes to concentrated regions of
the ERwhere lipid droplets are located and is also founddirectly
on lipid droplets themselves, we sought to determine whether
induction of lipid droplet biogenesis would cause DHRS3 to
concentrate to nascent lipid droplet monolayers. Stable poly-
clonal U2OS cells lines expressing either GFP or DHRS3-GFP
were subjected to oleic acid treatment for 12 h to induce tria-
cylglycerol synthesis and lipid droplet accumulation. DHRS3-
GFP expression demonstrated a marked concentration to lipid
droplets following treatment with oleic acid, with almost com-
plete diminishment of the ER signal intensity, whereas GFP
showed no alteration in localization (Fig. 6). These data support
the notion that DHRS3 is concentrated to regions of lipid drop-
let budding on the ER and will localize to the monolayer of de
novo lipid droplets.
Ectopic DHRS3 Expression Enhances Lipid Droplet Accu-
mulation—Because DHRS3 is localized to lipid droplets with
expression correlating to cell typeswith significant lipid droplet
accumulation, we investigated the contribution of DHRS3
expression to lipid droplet formation. U2OS cells, which have
undetectable endogenous levels of DHRS3 (data not shown),
were transfected with increasing levels of either GFP or
DHRS3-GFP and assessed for neutral lipid levels and lipid
droplet accumulation by LipidTOX Red staining. Expression
FIGURE 6. Lipid droplet formation induces delocalization of DHRS3 from the ER to lipid droplets. U2OS stable cell lines expressing GFP or DHRS3 GFP were
treated for 12 h with oleic acid to induce lipid droplet formation and accumulation. LipidTOX Red marks the lipid droplets, and DAPI marks the nucleus.
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levels of GFP had no effect on lipid droplet size, whereas
DHRS3-GFP expression resulted in increasingly larger perinu-
clear structures that were positive for neutral lipid staining (Fig.
7A). Although the most intense LipidTOX punctuate staining
appeared to coincide with lipid droplets, it was less clear what the
larger irregularbodies represented.Togain further insight into the
nature of the neutral lipid positive bodies, transmission electron
microscopy was utilized to visualize both lipid droplets and
DHRS3 in the GFP and DHRS3-GFP stable cell lines. Consistent
with the immunofluorescence data, GFP-expressing cells had
small, singular lipid droplets that stained negative forDHRS3 (Fig.
7B,panels 1 and3). Interestingly, theDHRS3-GFPexpressing cells
also contained small, singular droplets, but more so, there were
significant numbers of aggregated lipid droplets that were highly
enriched for DHRS3 labeling (Fig. 7B, panels 2 and 4). In some
cases, the droplets appeared to be of a more uniform size (Fig. 7B,
panel 4), and, in other cases, there was a clear size discrepancy
among the aggregated droplets (Fig. 7B, panel 2). The aggregated
bodies of droplets from the transmission electron microscopy
micrographs likely explain the irregular, neutral lipid bodies pres-
FIGURE 7. Ectopic DHRS3 expression enhances lipid droplet accumulation. A, U2OS cells were transfected with three different concentrations of GFP or
DHRS3-GFP and analyzed for lipid droplet accumulation. LipidTOX Red marks the lipid droplets. B, transmission electron microscopy of immunogold-labeled
ectopic DHRS3 in U2OS stable cell lines. U2OS monolayers were fixed, probed with -DHRS3 primary antibody, and visualized by transmission electron
microscopy. Representative lipid droplets (LD) are indicated. Panels 1 and 2 are 25,000 magnification and panels 3 and 4 are 50,000 magnification,
respectively.
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ent in the immunofluorescence data of DHRS3-GFP expression.
These results suggest that DHRS3may have a contributing role to
lipid droplet biogenesis and/or regulation.
p53 Induction of DHRS3 Correlates to Greater Lipid Droplet
Levels—Given the observations supporting DHRS3 as an ER
protein, the induction and accumulation ofDHRS3 at the ER by
p53 was assessed. MEF cells containing a p53ER allele and vari-
able Mdm2 status (Mdm2 WT, null, or carrying the C462A
allele) were fractionated biochemically into cytosolic and ER
enriched fractions in the absence or presence of the p53ER ago-
nist 4-OHT.Basal levels ofDHRS3were low inMdm2WTcells,
modestly higher inMdm2 null cells, and significantly higher in
the Mdm2 C462A cells. Induction of p53 over 24 h in the ER
enriched fractions resulted in increased DHRS3 levels in all
three genotypes, whereas levels of calreticulin exhibited no
change (Fig. 8A), providing further support for DHRS3 as a
p53-inducible endoplasmic reticulumprotein.Next, the contri-
bution of p53 induction to lipid droplet accumulation was
assessed. The same p53ER MEF cell lines were grown to con-
fluence and either treated with 4-OHT for 24 h or left
untreated. Visually, Mdm2 WT cells demonstrated no signifi-
cant difference in lipid droplet accumulation when assessed by
the degree of Oil RedO staining (Fig. 8B). However,Mdm2 null
cells exhibited increased staining, and strikingly, the Mdm2
C462A cells showed an even greater increase over all the geno-
types, particularly when contrasted to theMdm2WTcells. The
Oil Red O was extracted from the samples and measured by
spectrophotometry to quantitate total Oil RedO uptake.When
normalized to the protein extracted from each sample, the
quantified values showed a similar pattern to the microscopy
results.Mdm2WThad only amodest increase in lipid accumu-
lation, whereas the Mdm2 null and Mdm2 C462A cell lines
netted statistically significant intermediate and high levels of
neutral lipid accumulation following p53 activation, respec-
tively (Fig. 8C). Interestingly, the levels of Oil Red O across the
three types of MEF cells with different Mdm2 genotypes, an
indication of increased neutral lipid staining, are consistent
with the observed levels of p53 transactivation and DHRS3
expression (Fig. 1C).
To further assess the correlation of p53 to lipid droplet for-
mation, p53 WT and null MEF cells were grown to confluence
and then stained with Oil Red O. In the presence of p53, signif-
icantly more Oil Red O uptake was observed (Fig. 8D). This
pattern was consistent with 3T3-L1 cells that were transiently
infected with adenovirus overexpressing p53, where increased
neutral lipid staining was evident (Fig. 8E). Based on the obser-
vations that DHRS3 is an ER-derived lipid droplet protein
involved in the lipid droplet-mediated storage of retinol, it is
possible induction of Dhrs3 may be a component of a broader
p53-mediated metabolic program that modulates lipid accu-
mulation and lipid droplet biosynthesis. Future investigation is
necessary to further explore and validate these findings.
DISCUSSION
To date, p53 has been reported to be involved in a number of
aspects of normal cellular metabolism. Here, we report an
unexpected and novel role for p53 in retinoid metabolism with
implications for lipid droplet accumulation. As a novel meta-
bolic target gene of p53, DHRS3 is a well conserved protein that
is actively targeted to the endoplasmic reticulum. DHRS3
appears to concentrate to ER foci of lipid droplet formation,
where upon budding, DHRS3 is delocalized from the ER to the
ER-derived monolayer of nascent lipid droplets. Interestingly,
the degree of lipid droplet accumulation is dependent on the
relative activity of p53, which mirrors DHRS3 expression.
As the biologically active form of vitamin A, all-trans RA
exerts effects on cell proliferation, survival, and differentiation
bymodulating gene expression through the retinoic acid recep-
tors and retinoic X receptors (24). Retinol dehydrogenases oxi-
dize retinol to all-trans-retinaldehyde, which can be further
oxidized to RA via retinaldehyde degydrogenases (6). Con-
versely, retinol can be esterified to retinyl esters primarily by the
enzyme lecithin:retinol acyltransferase (LRAT) (25).Hence, the
bioavailability of free RA is, in part, regulated by the fluctuation
of oxidized and reduced forms of retinol. The compartmental-
ization and sequestration of retinol in lipid droplets may pro-
vide a mechanism for regulating retinol concentrations.
BecauseDHRS3 is a retinaldehyde reductase that promotes ret-
inol storage (10), modulating expression levels may be one way
of limiting the activity of RA.
The liver contains a specialized cell population, hepatic stel-
late cells (HSCs), which are largely responsible for storing the
majority of liver retinol (7). One characteristic feature of HSCs
is the presence of large cytoplasmic lipid droplets, where retinyl
esters are estimated to comprise upwards of 50% of the total
droplet content (26). HSCs are alsomaintained in a temporarily
arrested, or quiescent, phase of the cell cycle. Following liver
injury, HSCs are activated and primed to enter the cell cycle
where depletion of cytoplasmic lipid droplets coincides with
HSC proliferation and potentially contributes, in an unknown
manner, to the development of hepatic fibrosis (27). Interest-
ingly, p53 has been reported to play a role in cellular quiescence
where modest and transient activation, in the absence of overt
genotoxic stress, can trigger a reversible arrest from the cell
cycle (28, 29). To date, there is no known role for p53 in HSC
cell cycle dynamics. However, low level activation of p53 could
have a 2-fold effect by regulating cell cycle related genes to
promote HSC quiescence, as well as driving DHRS3 expression
FIGURE 8. p53 induction of DHRS3 correlates to greater lipid droplet levels. A, mouse embryonic fibroblasts harboring a single p53ER fusion allele and a
single p53 null allele (p53 ER/- MEF) cell lines with the indicated Mdm2 genotypes were treated for 24 h with 4-OHT. Cells were harvested and partitioned into
cytosolic-enriched (Cyto) or ER-enriched fractions and analyzed by Western blot. Actin is a cytosolic marker, and calreticulin (Calr) is an ER marker. B, p53 ER/-
MEF cell lines with the indicated Mdm2 genotypes were treated for 24 h with 4-OHT and stained with Oil Red O (ORO). Cells were visualized for Oil Red O uptake
by fluorescence microscopy. Phase contrast image (Phase) is shown for cell density control. C, Oil Red O was extracted from samples in B and analyzed by
spectrophotometry. The ratio of total Oil Red O absorbance per milligram of protein was used to quantitate total values. p values are shown for statistically
significant samples. Error bars represent S.E. D, p53 / and / MEF cells were grown to confluence and stained with Oil Red O. Stain uptake was visualized
by phase-contrast and fluorescence microscopy. E, 3T3-L1 preadipocytes were either transduced with adenovirus expressing p53 or left untreated. Cells were
stained with Oil Red O 24 h post-transduction.
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where the subsequent increase in retinol levels would contrib-
ute to the observed increase in cytoplasmic lipid droplet volume
and number (30). Sequestration of retinol in cytoplasmic lipid
droplets may also potentially limit activity of biologically active
retinoids, which have been implicated in promoting liver fibro-
sis (31), thereby providing potential indirect crosstalk between
p53 and retinoid activated nuclear receptors.
As mentioned previously, adipocytes are the second most
abundant storage site for retinoids, where they are estimated to
harbor upwards of 20% of total body retinol. Retinoids play an
important role in adipogenesis (32), where the primary oxida-
tion products of retinol, retinaldehyde, and retinoic acid, have
both been demonstrated to suppress adipocyte differentiation
in the early stages of maturation (33, 34). Interestingly, another
oxidoreductase associatedwith retinoidmetabolismand adipo-
genesis is retinol saturase; a direct target gene of peroxisome
proliferator-activated receptor , one of the master regulators
of adipogenesis, with expression induced during the initial
phase of differentiation (35). Retinol saturase is an enzyme that
catalyzes the conversion of all-trans-retinol to all-trans-13,14-
dihydroretinol and, similar to DHRS3, is also an endoplasmic
reticulum protein (36). Given our observations that DHRS3 is
induced during adipogenesis and is a component of the ER and
lipid droplets, it may be possible that DHRS3 is part of a suite of
retinoid modulating enzymes that are specific to a subset of
specialized lipid droplets that regulate cytosolic retinol concen-
trations in an effort to control the adipogenic program.
The mechanisms surrounding lipid droplet formation, accu-
mulation, and homeostasis are relatively unclear. Here, we
present the surprising finding that p53 activation promotes
lipid droplet accumulation in the subset of cell types examined.
This observation is supported by evidence in rat glioma C6
cells, which harbor WT p53, where growth compromised cells
were shown to accumulate intracellular lipid droplets (37).
LRAT knock-out mice, which are deficient in retinol storage,
were found to be completely absent of lipid droplets in hepatic
stellate cells (25). Here, we demonstrate that DHRS3 overex-
pression also increased lipid droplet numbers. In conjunction
with the LRAT study, this suggests that the enzymes promoting
retinol storage may be implicated in promoting lipid droplet
formation. In addition, dietary retinoid levels have a profound
effect on neutral lipid uptake in lipid droplets (26), suggesting
that increased retinol levels promote enhanced triacylglycerol
storage in lipid droplets. Taken together, p53 mediated induc-
tion of DHRS3may promote formation of retinol specific lipid
droplets by increasing intracellular retinol levels and enhancing
triacylglycerol storage to coincide with a proper stoichiometric
balance of retinyl esters in nascent lipid droplets. During con-
ditions where cells are not proliferating, lipid droplet storage of
retinol could act as a holding phase for biologically active reti-
noids that may otherwise function during an active cell cycle to
modulate gene expression. In addition, p53-directed storage of
neutral lipids could provide a means to accumulate lipid sub-
strates, which become important for the biosynthesis of new
daughter cell membranes, as well as serving as a potential
energy source, during phases of active cell growth and division.
The same aspects of cell proliferation and differentiation that
are modulated by retinoids in normal cells are also regulated in
cancer cells. DHRS3 expression was shown to be up-regulated
in transformed buccal keratinocytes (38), papillary thyroid car-
cinomas (39, 40), and neuroblastomas (41). The up-regulated
expression may limit the activity of RA, which is generally
thought to have an inhibitory effect on the cell cycle and pro-
mote apoptosis in some cancer cell lines (6), thereby exerting a
prosurvival effect. However, despite the enhanced expression,
DHRS3 was negatively correlated with metastasis in papillary
thyroid carcinomas (39), associated with better prognosis in
neuroblastoma (41), and found to have a methylated promoter,
an indicator of gene silencing, in a subset of human malignant
melanomas (42), all consistent with a potential favorable role in
tumor suppression. Given the well established role of p53 in
tumor suppression and the validation of DHRS3 as a bona fide
p53 target gene (17), it will be worthwhile to investigate any
potential cross-talk between p53, DHRS3, and retinoid signal-
ing as they relate to inhibition or promotion of tumor initiation
and progression.
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